Labtec opens drug-delivery facility in Hamburg; Nano pioneer Mauro Ferrari honored;

> Labtec opens state-of-the-art manufacturing facility in Hamburg. In-PharmaTechnologist reports that the new site will become "Europe's most modern manufacturing facility for the production of transdermal drug delivery systems." Story

> Nanotechnology pioneer Mauro Ferrari, president and CEO of The Methodist Hospital Research Institute in Houston, has received the 2011 CRS Founders' Award, honors leaders in drug delivery science and technology. Ferrari has pioneered the use of nanotechnology in controlled release of medicine. Release

> Drug-delivery firm pharmaCline makes Sioux Falls its headquarters. Story

> Addressing Brain Tumors with Targeted Gold Nanoparticles: A New Gold Standard for Hydrophobic Drug Delivery? More here

> Drug delivery abstract of the week: Semi-solid Sucrose Stearate-Based Emulsions as Dermal Drug Delivery Systems Abstract

> Drug delivery patent application of the week: Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance Patent Application

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.